| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ra Capital Management LP | Director | 2026-03-30 | 971,091 | $6.50 | $6.31MBuy |
| Ra Capital Management LP | Director | 2026-03-27 | 2,495,623 | $6.43 | $16.05MBuy |
| Ra Capital Management LP | Director | 2026-03-26 | 351,224 | $6.38 | $2.24MBuy |
| Ra Capital Management LP | Director | 2026-03-26 | 4,954,558 | $6.06 | $30.02MBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 15,294 | $4.75 | $72.65kBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 15,294 | $15.00 | $229.41kSell |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 17,900 | $3.87 | $69.27kBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 17,900 | $15.09 | $270.18kSell |
| Paul Bolno | President and CEO | 2026-02-09 | 10,480 | $13.45 | $140.96kSell |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-09 | 1,883 | $13.45 | $25.33kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gsk PLC | 15.04% | 28,929,452 | $165.77M | Insider |
| Ra Capital Management LP | 14.02% | 26,975,505 | $154.57M | Institution |
| Gsk PLC | 9.48% | 18,245,691 | $104.55M | Institution |
| Blackrock Inc | 7.34% | 14,117,412 | $80.89M | Institution |
| Maverick Capital Ltd | 5.28% | 10,161,399 | $58.22M | Institution |
| Ken Takanashi | 5.01% | 9,630,351 | $55.18M | Insider |
| Price T Rowe Associates Inc | 4.52% | 8,704,550 | $49.88M | Institution |
| Ra Capital Management LP | 3.95% | 7,602,428 | $43.56M | Insider |
| Driehaus Capital Management LLC | 2.82% | 5,431,021 | $31.12M | Institution |
| Federated Hermes Inc | 2.76% | 5,317,457 | $30.47M | Institution |